Cognitive Muscular Therapy - developing a training programme for physiotherapists

Not Applicable

• Conditions: ow back pain; Musculoskeletal Diseases

• Registration Number: ISRCTN31860277
• Lead Sponsor: niversity of Salford

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2024-06-21
• Last Update Posted: 8 July 2024
• Study Completion: 2025-03-28

Recruitment & Eligibility

• Status: Ongoing
• Sex: All
• Target Recruitment: 15

Inclusion Criteria

1. Adults presenting with low back pain (LBP) pain duration >3 months and considered at high risk of poor long-term outcome (identified with STarTBack 9item tool)
2. Currently scoring 4 or more on a numerical response scale for pain from 0-10 (0 = no pain, 10 = worst pain)
3. Ability to stand for 10 minutes and walk for 5 minutes (required to complete the intervention)
4. Speak and understand English sufficiently to read the information sheet and sign the consent form

Exclusion Criteria

1. Diagnosis of inflammatory arthritis
2. LBP due to pregnancy and up to 12 months post pregnancy
3. Previous spinal surgery such as discectomy, anterior cervical discectomy and fusion, disc replacement, laminectomy and scoliosis fixation
4. Diagnosis of degenerative neurological disorders (e.g. multiple sclerosis/Parkinson’s disease)
5. BMI of more than 33 (as increased subcutaneous fat prevents the collection of surface EMG signals)
6. Pending litigation related to an injury, for example, at work or whilst driving
7. Vulnerable patients, for example, those who lack the mental capacity to make decisions, have dementia or are nearing the end of life

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1. Pain measured using the Numerical Rating of Pain Scale at baseline and 10 weeks<br>2. Disability measured using the Roland Morris Disability Questionnaire at baseline and 10 weeks<br>3. Catastrophising measured using the Pain Catastrophising Scale (PCS) at baseline and 10 weeks<br>4. Risk of chronic pain measured using the STarT Back Screening Tool at baseline and 10 weeks<br>

Secondary Outcome Measures

Name	Time	Method
There are no secondary outcome measures